Podocytes are lost from glomeruli before completing apoptosis.


Journal

American journal of physiology. Renal physiology
ISSN: 1522-1466
Titre abrégé: Am J Physiol Renal Physiol
Pays: United States
ID NLM: 100901990

Informations de publication

Date de publication:
01 11 2022
Historique:
pubmed: 2 9 2022
medline: 22 10 2022
entrez: 1 9 2022
Statut: ppublish

Résumé

Although apoptosis of podocytes has been widely reported in in vitro studies, it has been less frequently and less definitively documented in in vivo situations. To investigate this discrepancy, we analyzed the dying process of podocytes in vitro and in vivo using LMB2, a human (h)CD25-directed immunotoxin. LMB2 induced cell death within 2 days in 56.8 ± 13.6% of cultured podocytes expressing hCD25 in a caspase-3, Bak1, and Bax-dependent manner. LMB2 induced typical apoptotic features, including TUNEL staining and fragmented nuclei without lactate dehydrogenase leakage. In vivo, LMB2 effectively eliminated hCD25-expressing podocytes in NEP25 mice. Podocytes injured by LMB2 were occasionally stained for cleaved caspase-3 and cleaved lamin A but never for TUNEL. Urinary sediment contained TUNEL-positive podocytes. To examine the effect of glomerular filtration, we performed unilateral ureteral obstruction in NEP25 mice treated with LMB2 1 day before euthanasia. In the obstructed kidney, glomeruli contained significantly more cleaved lamin A-positive podocytes than those in the contralateral kidney (50.1 ± 5.4% vs. 29.3 ± 4.1%,

Identifiants

pubmed: 36049065
doi: 10.1152/ajprenal.00080.2022
pmc: PMC9602714
doi:

Substances chimiques

Caspase 3 EC 3.4.22.-
Immunotoxins 0
Lamin Type A 0
bcl-2-Associated X Protein 0
Lactate Dehydrogenases EC 1.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

F515-F526

Références

J Am Soc Nephrol. 2011 Jul;22(7):1275-85
pubmed: 21719786
Proc Natl Acad Sci U S A. 2020 Mar 17;117(11):6086-6091
pubmed: 32123080
J Cell Mol Med. 2018 Nov;22(11):5450-5467
pubmed: 30187999
Clin J Am Soc Nephrol. 2012 Sep;7(9):1385-93
pubmed: 22700887
J Immunol. 2000 Dec 15;165(12):7150-6
pubmed: 11120846
J Am Soc Nephrol. 2005 Jul;16(7):1936-47
pubmed: 15843472
Kidney Int. 2005 Feb;67(2):404-19
pubmed: 15673288
Int J Mol Sci. 2021 Jan 02;22(1):
pubmed: 33401733
J Am Soc Nephrol. 2005 Apr;16(4):1013-23
pubmed: 15758046
Cytometry. 2001 Dec 1;45(4):237-43
pubmed: 11746092
Nat Med. 2008 Mar;14(3):290-8
pubmed: 18311147
Cell Stem Cell. 2016 Oct 6;19(4):516-529
pubmed: 27570066
Sci Rep. 2016 Mar 03;6:22579
pubmed: 26934958
Kidney Int. 2001 Sep;60(3):957-68
pubmed: 11532090
Biochim Biophys Acta. 2013 Dec;1833(12):3481-3498
pubmed: 23830918
J Cell Biol. 2001 Oct 29;155(3):459-70
pubmed: 11684710
Dev Biol. 2008 Apr 15;316(2):288-301
pubmed: 18328474
J Am Soc Nephrol. 2001 Oct;12(10):2060-2071
pubmed: 11562404
J Clin Invest. 2001 Sep;108(6):807-16
pubmed: 11560950
Cancer Res. 1998 Mar 1;58(5):968-75
pubmed: 9500458
J Biol Chem. 2001 Mar 9;276(10):7320-6
pubmed: 11058599
Am J Physiol Renal Physiol. 2014 Jan;306(2):F205-13
pubmed: 24226527
Toxicol Pathol. 2007 Jun;35(4):495-516
pubmed: 17562483
Am J Physiol Renal Physiol. 2021 May 1;320(5):F922-F933
pubmed: 33719575
Kidney Int. 2005 Sep;68(3):1048-60
pubmed: 16105035
J Biol Chem. 2004 Aug 27;279(35):37004-12
pubmed: 15213232
Nat Rev Nephrol. 2013 Apr;9(4):200-10
pubmed: 23338211
Am J Physiol Renal Physiol. 2019 Feb 1;316(2):F241-F252
pubmed: 30379099
Biomolecules. 2020 Jun 30;10(7):
pubmed: 32630017
Methods Mol Biol. 2014;1133:141-54
pubmed: 24567100
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Kidney Res Clin Pract. 2018 Sep;37(3):210-221
pubmed: 30254845
Diabetologia. 2012 Nov;55(11):2913-9
pubmed: 22854890
Eur J Cell Biol. 2002 Dec;81(12):677-91
pubmed: 12553668
J Am Soc Nephrol. 2015 Feb;26(2):258-69
pubmed: 25060060
J Biol Chem. 1996 Jul 12;271(28):16443-6
pubmed: 8663580
Kidney Int. 2018 Apr;93(4):903-920
pubmed: 29398135
Kidney Int. 1999 May;55(5):1763-75
pubmed: 10231439
Nephron. 2001 Nov;89(3):342-7
pubmed: 11598401
J Am Soc Nephrol. 2003 Mar;14(3):806-14
pubmed: 12595519
Physiol Rev. 2003 Jan;83(1):253-307
pubmed: 12506131
Jpn J Cancer Res. 1990 Sep;81(9):902-8
pubmed: 2121691
Exp Ther Med. 2013 May;5(5):1322-1326
pubmed: 23737872
BMC Nephrol. 2015 Mar 29;16:38
pubmed: 25884163
Development. 2004 Jan;131(2):275-84
pubmed: 14668412
Cell Death Differ. 2003 Jan;10(1):76-100
pubmed: 12655297
Cell Death Differ. 2018 Mar;25(3):486-541
pubmed: 29362479

Auteurs

Kazuyoshi Yamamoto (K)

Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Department of Basic Medicine, Tokai University School of Medicine, Isehara, Japan.

Masahiro Okabe (M)

Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Department of Basic Medicine, Tokai University School of Medicine, Isehara, Japan.

Keiko Tanaka (K)

Department of Basic Medicine, Tokai University School of Medicine, Isehara, Japan.

Takashi Yokoo (T)

Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.

Ira Pastan (I)

Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Toshikazu Araoka (T)

Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.

Kenji Osafune (K)

Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.

Tomohiro Udagawa (T)

Department of Basic Medicine, Tokai University School of Medicine, Isehara, Japan.

Masahiro Koizumi (M)

Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.

Taiji Matsusaka (T)

Department of Basic Medicine, Tokai University School of Medicine, Isehara, Japan.
Institute of Medical Science, Tokai University School of Medicine, Isehara, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH